查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1338939

肌腱炎治疗市场、份额、市场规模、趋势、行业分析报告：按治疗、按症状、按地区、按细分市场、预测，2023-2032 年

Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球肌腱炎治疗市场规模预计将达到2,916.4亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

多种类型的运动相关损伤的负担日益加重，新产品和技术的不断创新，缩短康復时间并提供更好治疗设施的治疗方法，以及世界各地政府组织不断加大的努力。推动市场成长的关键因素。 此外，骨科手术的高普及率、已建立的医疗基础设施和治疗设施以及主要参与者实施产品组合扩张可能会以更快的速度刺激全球市场。 例如，2022年11月，Camber Pharmaceuticals增加了一款新产品 "□普生口服混悬液" 。 这种新开发的产品适用于治疗肌腱炎症状。

世界各地的患者越来越多地寻求更多的非侵入性治疗，以最大限度地减少停机时间并加快康復速度，包括物理治疗、超音波治疗和衝击波治疗。推动了治疗需求。 此外，肌腱置换和再生技术的不断创新正在满足对替代性人工组织快速增长的需求，对市场产生积极影响。 一种透过将患者的血小板注射到受影响的肌腱中刺激组织修復来促进癒合的新型治疗方法越来越受欢迎，这种治疗方法用于治疗肘部、肩部和膝盖的肌腱炎，在治疗中已显示出希望。癌症，并在世界各地获得了极大的普及和关注。

除此之外，随着医疗技术的快速进步，现在世界各地出现了不同类型的肌腱炎创新治疗方法，包括药物治疗、物理治疗和手术治疗，使得治疗效果和效率不断提高。 儘管如此，早期诊断的重要性日益得到认可和广泛传播，为市场创造了巨大的成长机会。

肌腱炎治疗市场报告亮点

治疗产业在 2022 年占据最大的市场份额，这主要是由于物理治疗的采用，因为它能够让患者放心，并且作为一种具有成本效益的选择而广受欢迎。

由于人们生活方式和体育活动倾向的不断变化，高尔夫球手的肘部部分预计在预测期内将以最高的复合年增长率增长。

由于人民消费能力不断增强、基础设施发达以及与医疗技术公司合作的渗透率较高，北美地区在2022年将占据全球市场的最大份额。

全球主要市场参与者包括 Almatica Pharma、Teva Pharmaceuticals Industries、Abbott Laboratories、Stryker Corporation、Ingelheim Pharmaceuticals 和 Zimmer Biomet Holdings。

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第4章全球肌腱炎治疗市场洞察

  • 肌腱炎治疗市场 - 产业概况
  • 肌腱炎治疗市场动态
    • 推动者和机会
      • 运动伤害增加
      • 提高对肌腱炎治疗方案的认识
    • 抑制因素和挑战
      • 新兴国家的保险覆盖范围有限
  • 杵分析
  • 肌腱炎治疗产业的趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第5章全球肌腱炎治疗市场（依治疗）

  • 主要发现
  • 简介
  • 治疗
  • 手术

第 6 章全球肌腱炎治疗市场（依症状）

  • 主要发现
  • 简介
  • 网球肘
  • 高尔夫球肘
  • 投手肘
  • 跳线膝盖
  • 游泳者的肩膀
  • 跟腱炎

第 7 章全球肌腱炎治疗市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年肌腱炎治疗市场评估（按地区）
  • 肌腱炎治疗市场 - 北美
    • 北美：肌腱炎治疗市场，依症状，2019-2032 年
    • 北美：肌腱炎治疗市场（依治疗方式），2019-2032 年
    • 肌腱炎治疗市场 - 美国
    • 肌腱炎治疗市场 - 加拿大
  • 肌腱炎治疗市场 - 欧洲
    • 欧洲：肌腱炎治疗市场，依情况划分，2019-2032 年
    • 欧洲：肌腱炎治疗市场（依治疗方式），2019-2032 年
    • 肌腱炎治疗市场 - 英国
    • 肌腱炎治疗市场 - 法国
    • 肌腱炎治疗市场 - 德国
    • 肌腱炎治疗市场 - 义大利
    • 肌腱炎治疗市场 - 西班牙
    • 肌腱炎治疗市场 - 荷兰
    • 肌腱炎治疗市场 - 俄罗斯
  • 肌腱炎治疗市场 - 亚太地区
    • 亚太地区：肌腱炎治疗市场，依症状，2019-2032 年
    • 亚太地区：肌腱炎治疗市场（依治疗方式），2019-2032 年
    • 肌腱炎治疗市场 - 中国
    • 肌腱炎治疗市场 - 印度
    • 肌腱炎治疗市场 - 马来西亚
    • 肌腱炎治疗市场 - 日本
    • 肌腱炎治疗市场—印度尼西亚
    • 肌腱炎治疗市场 - 韩国
  • 肌腱炎治疗市场 - 中东和非洲
    • 中东和非洲：肌腱炎治疗市场（按症状），2019-2032 年
    • 中东与非洲：肌腱炎治疗市场（依治疗方式），2019-2032 年
    • 肌腱炎治疗市场 - 沙乌地阿拉伯
    • 肌腱炎治疗市场 - 阿拉伯联合大公国
    • 肌腱炎治疗市场 - 以色列
    • 肌腱炎治疗市场 - 南非
  • 肌腱炎治疗市场 - 拉丁美洲
    • 拉丁美洲：肌腱炎治疗市场（按症状），2019-2032 年
    • 拉丁美洲：肌腱炎治疗市场（依治疗方式），2019-2032 年
    • 肌腱炎治疗市场 - 墨西哥
    • 肌腱炎治疗市场 - 巴西
    • 肌腱炎治疗市场 - 阿根廷

第8章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第9章公司简介

  • Teva Pharmaceuticals
  • Almatica Pharma
  • Abbott
  • Boehringer Ingelheim
  • Bayer
  • Merck
  • Pfizer
  • Teikoku Pharma
  • Stryker Corporation
  • 3M Company
  • Zimmer Biomet
  • AKSIGEN
  • DJO Global
  • AstraZeneca
  • GlaxoSmithKline
  • Camber Pharmaceuticals
  • CoNextions Inc
Product Code: PM3383

The global tendonitis treatment market size is expected to reach USD 291.64 billion by 2032, according to a new study by Polaris Market Research. The report "Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising burden of several types of sports-related injuries, constant innovations of new products and technologies, and treatment modalities to offer better treatment facilities with less recovery time, along with the growing efforts undertaken by government organizations worldwide, are among the leading factors driving the market growth. Moreover, the high prevalence of orthopedic procedures, and presence of well-established healthcare infrastructure and treatment facilities, and the implementation of product portfolio expansion by major players, will further stimulate the global market at a significant pace. For instance, in November 2022, Camber Pharmaceuticals added a new product, "Naproxen Oral Suspension." The newly developed product is being indicated to treat the symptoms of tendonitis.

Patients across the globe are increasingly seeking more non-invasive treatment options that offer minimal downtime and faster recovery times, which fuels the demand for therapies such as physical therapy, ultrasound therapy, and shockwave therapy. Additionally, the continuous innovations in tendon replacement and regeneration techniques address the surging demand for alternative engineered tissue and positively influence the market. There has been a significant rise in the penetration for a new kind of treatment, which involves injecting a patient's platelets into the affected tendon to promote healing that can stimulate tissue repair, and the therapy has shown promise in treating tendonitis in the elbow, shoulder, and knee, which is gaining huge popularity and traction all over the world.

Apart from this, with the rapid advances in medical technology, various types of innovative treatment options are available worldwide for tendonitis, including medications, physical therapy, and surgery, which led to increased effectiveness and efficiency of treatment. Despite this, there is an emerging prevalence and awareness regarding the importance of early diagnosis, which creates huge growth opportunities for the market.

Tendonitis Treatment Market Report Highlights

Therapy segment accounted for largest market share in 2022, which is mainly driven by adoption of physical therapy due to its ability to relive patients and its popularity as a cost-efficient option

Golfer's elbow segment is expected to grow at a highest CAGR during the anticipated period, on account of constant changes in people lifestyles and inclination towards sports activity

North America region dominated the global market with maximum share in 2022, owing to increase in people spending capacity, presence of well-developed infrastructure, and high penetration to collaborate with med-tech companies

The global key market players Almatica Pharma, Teva Pharmaceuticals Industries, Abbott Laboratories, Stryker Corporation, Ingelheim Pharmaceuticals, and Zimmer Biomet Holdings

Polaris Market Research has segmented the tendonitis treatment market report based on treatment, condition, and region:

Tendonitis Treatment, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

  • Therapy
  • Surgery

Tendonitis Treatment, Condition Outlook (Revenue - USD Billion, 2019 - 2032)

  • Tennis Elbow
  • Golfer's Elbow
  • Pitcher's Elbow
  • Jumper's Knee
  • Swimmer's Shoulder
  • Achille Tendonitis

Tendonitis Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Tendonitis Treatment Market Insights

  • 4.1. Tendonitis Treatment Market - Industry Snapshot
  • 4.2. Tendonitis Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of sports injuries
      • 4.2.1.2. Growing awareness of tendonitis treatment options
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Insurance coverage is limited in emerging countries
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Tendonitis Treatment Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Tendonitis Treatment Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Tendonitis Treatment, by Treatment, 2019-2032 (USD Billion)
  • 5.3. Therapy
    • 5.3.1. Global Tendonitis Treatment Market, by Therapy, by Region, 2019-2032 (USD Billion)
  • 5.4. Surgery
    • 5.4.1. Global Tendonitis Treatment Market, by Surgery, by Region, 2019-2032 (USD Billion)

6. Global Tendonitis Treatment Market, by Condition

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • 6.3. Tennis Elbow
    • 6.3.1. Global Tendonitis Treatment Market, by Tennis Elbow, by Region, 2019-2032 (USD Billion)
  • 6.4. Golfer's Elbow
    • 6.4.1. Global Tendonitis Treatment Market, by Golfer's Elbow, by Region, 2019-2032 (USD Billion)
  • 6.5. Pitcher's Elbow
    • 6.5.1. Global Tendonitis Treatment Market, by Pitcher's Elbow, by Region, 2019-2032 (USD Billion)
  • 6.6. Jumper's Knee
    • 6.6.1. Global Tendonitis Treatment Market, by Jumper's Knee, by Region, 2019-2032 (USD Billion)
  • 6.7. Swimmer's Shoulder
    • 6.7.1. Global Tendonitis Treatment Market, by Swimmer's Shoulder, by Region, 2019-2032 (USD Billion)
  • 6.8. Achilles Tendonitis
    • 6.8.1. Global Tendonitis Treatment Market, by Achilles Tendonitis, by Region, 2019-2032 (USD Billion)

7. Global Tendonitis Treatment Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Tendonitis Treatment Market - North America
    • 7.3.1. North America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.3.2. North America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.3.3. Tendonitis Treatment Market - U.S.
      • 7.3.3.1. U.S.: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.3.4. Tendonitis Treatment Market - Canada
      • 7.3.4.1. Canada: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.4. Tendonitis Treatment Market - Europe
    • 7.4.1. Europe: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.3. Tendonitis Treatment Market - UK
      • 7.4.3.1. UK: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.4. Tendonitis Treatment Market - France
      • 7.4.4.1. France: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.5. Tendonitis Treatment Market - Germany
      • 7.4.5.1. Germany: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.6. Tendonitis Treatment Market - Italy
      • 7.4.6.1. Italy: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.7. Tendonitis Treatment Market - Spain
      • 7.4.7.1. Spain: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.8. Tendonitis Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.4.9. Tendonitis Treatment Market - Russia
      • 7.4.9.1. Russia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.5. Tendonitis Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.3. Tendonitis Treatment Market - China
      • 7.5.3.1. China: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.4. Tendonitis Treatment Market - India
      • 7.5.4.1. India: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.5. Tendonitis Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.6. Tendonitis Treatment Market - Japan
      • 7.5.6.1. Japan: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.7. Tendonitis Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.5.8. Tendonitis Treatment Market - South Korea
      • 7.5.8.1. South Korea: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.6. Tendonitis Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.3. Tendonitis Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.4. Tendonitis Treatment Market - UAE
      • 7.6.4.1. UAE: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.5. Tendonitis Treatment Market - Israel
      • 7.6.5.1. Israel: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.6.6. Tendonitis Treatment Market - South Africa
      • 7.6.6.1. South Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • 7.7. Tendonitis Treatment Market - Latin America
    • 7.7.1. Latin America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.3. Tendonitis Treatment Market - Mexico
      • 7.7.3.1. Mexico: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.4. Tendonitis Treatment Market - Brazil
      • 7.7.4.1. Brazil: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
    • 7.7.5. Tendonitis Treatment Market - Argentina
      • 7.7.5.1. Argentina: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Teva Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Almatica Pharma
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Abbott
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boehringer Ingelheim
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Bayer
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Merck
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Pfizer
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Teikoku Pharma
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Stryker Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. 3M Company
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Zimmer Biomet
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. AKSIGEN
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. DJO Global
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. AstraZeneca
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. GlaxoSmithKline
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Camber Pharmaceuticals
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. CoNextions Inc
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development

List of Tables

  • Table 1 Global Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 2 Global Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 3 Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 5 North America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 6 U.S.: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 7 U.S.: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 8 Canada: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 9 Canada: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 10 Europe: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 11 Europe: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 12 UK: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 13 UK: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 14 France: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 15 France: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 16 Germany: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 17 Germany: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 18 Italy: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 19 Italy: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 20 Spain: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 21 Spain: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 24 Russia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 25 Russia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 28 China: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 29 China: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 30 India: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 31 India: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 34 Japan: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 35 Japan: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 38 South Korea: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 39 South Korea: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 44 UAE: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 45 UAE: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 46 Israel: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 47 Israel: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 48 South Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 49 South Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 50 Latin America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 51 Latin America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 52 Mexico: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 53 Mexico: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 54 Brazil: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 55 Brazil: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
  • Table 56 Argentina: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
  • Table 57 Argentina: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Tendonitis Treatment Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Condition
  • Figure 7 Global Tendonitis Treatment Market, by Condition, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Treatment
  • Figure 9 Global Tendonitis Treatment Market, by Treatment, 2022 & 2032 (USD Billion)
  • Figure 10 Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Tendonitis Treatment Market